Melanocortin research
01Quality sourced02Secure shipping
Approved drug exists 10 in stock
Melanocortin research
PT-141
Strength · 10 MGMelanocortin-receptor agonist studied for desire signaling; bremelanotide is approved for a defined form of HSDD.
Price$50USD
Add this item now, then send the complete order from your cart.
Research overview
PT-141
in context.
PT-141, or bremelanotide, activates central melanocortin receptors involved in sexual-desire signaling. An approved bremelanotide medicine is indicated for acquired, generalized hypoactive sexual desire disorder in certain premenopausal women.
Research highlights
- 01Central melanocortin pathway
- 02Desire-signaling research
- 03Established approved-drug evidence
Product details
- Presentation
- 10 MG
- Availability
- Available now · 10
- Ordering
- Cart checkout with a ready-to-send order message
- Intended use
- Laboratory, analytical, or educational research
For research use only. Not for human or veterinary consumption. No dosage, administration, medical advice, or research protocols are provided.
Explore the catalog